Skip to main content
logo
Molecular Partners AG (SWX:MOLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
3.330
-0.010 (-0.30%)
Jul 31, 2026, 5:30 PM CET

Molecular Partners AG Financials Overview

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--4.977.04189.69.75
Revenue Growth
---29.38%-96.29%1843.82%4.39%
Gross Profit
-36.66-39.14-42.53-40.81139.71-45.21
Operating Income
-52.74-55.44-61.22-61.11116.61-63.42
Net Income
-58.02-61.65-54.04-61.98117.85-63.79
Earnings Per Share
-1.55-1.65-1.59-1.893.54-2.06
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
78.7793.06149.44186.89249.14132.81
Total Debt
3.343.642.443.654.856.04
Net Cash (Debt)
75.4289.41147183.24244.29126.77
Net Cash Growth
-41.43%-39.17%-19.78%-24.99%92.70%-23.86%
Net Cash Per Share
2.022.404.325.597.344.09

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-48.42-51.26-59.25-59.01118.57-90.95
Capital Expenditures
-0.27-0.71-0.71-0.58-1.18-0.93
Free Cash Flow
-48.69-51.97-59.95-59.58117.39-91.89
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----73.68%-
Operating Margin
---1231.73%-868.26%61.50%-650.17%
Pretax Margin
---1087.34%-880.70%62.16%-653.92%
Profit Margin
---1087.38%-880.71%62.16%-653.94%
FCF Margin
---1206.30%-846.55%61.91%-942.03%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----1.70-
Forward PE
-10.2610.2610.2610.2611.96
P/FCF Ratio
----1.71-
PS Ratio
--30.1116.061.0659.00